Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Kangji Medical Holdings Limited ( (HK:9997) ) is now available.
Kangji Medical Holdings Limited has announced an update on its privatization proposal by Knight Bidco Limited through a scheme of arrangement. The company is in the process of finalizing the Scheme Document, with a court hearing scheduled for October 6, 2025. The proposal’s implementation is contingent on fulfilling certain conditions, including court approval. Additionally, the company clarified that Bin Yuan Capital Limited and LYFE Capital Management Limited are not current shareholders.
The most recent analyst rating on (HK:9997) stock is a Buy with a HK$10.00 price target. To see the full list of analyst forecasts on Kangji Medical Holdings Limited stock, see the HK:9997 Stock Forecast page.
More about Kangji Medical Holdings Limited
Kangji Medical Holdings Limited is a company incorporated in the Cayman Islands, focusing on the medical industry. It is involved in the development and provision of medical devices and solutions.
Average Trading Volume: 5,577,334
Technical Sentiment Signal: Buy
Current Market Cap: HK$10.5B
For an in-depth examination of 9997 stock, go to TipRanks’ Overview page.